People · Operator

George Kromer

Named in public records as an officer, director or promoter · active 2010–2010 · Other Health Care

1
Companies
1
Filings
$10.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Bovie Medical CorpOther Health CareSeries A$10.0M$141.3M2010
Operator network

George Kromer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

MICHAEL NORMAN · 4 companies · 1 sharedMICHAEL NORMANGary Pickett · 2 companies · 1 sharedGary PickettRobert Gershon · 2 companies · 1 sharedRobert GershonAndrew Makrides · 1 companies · 1 sharedAndrew MakridesAugust Lentricchia · 1 companies · 1 sharedAugust LentricchiaGregory Konesky · 1 companies · 1 sharedGregory KoneskyIan Sheffield · 1 companies · 1 sharedIan SheffieldJ. Robert Saron · 1 companies · 1 sharedJ. Robert SaronLawrence J. Waldman · 1 companies · 1 sharedLawrence J. Waldm…Michael Geraghty · 1 companies · 1 sharedMichael GeraghtyMoshe Citronowicz · 1 companies · 1 sharedMoshe CitronowiczMoshe Citronowitz · 1 companies · 1 sharedMoshe CitronowitzPeter Pardoll · 1 companies · 1 sharedPeter PardollSteve Livneh · 1 companies · 1 sharedSteve LivnehSteven Maclaren · 1 companies · 1 sharedSteven MaclarenBovie Medical Corp · $10.0M raisedBovie Medical CorpGeorge KromerGK
George Kromer Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside George Kromer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
MICHAEL NORMAN14
Robert Gershon12
Gary Pickett12
Moshe Citronowitz11
Andrew Makrides11
Michael Geraghty11
J. Robert Saron11
Ian Sheffield11
Lawrence J. Waldman11
Peter Pardoll11
Gregory Konesky11
Moshe Citronowicz11
August Lentricchia11
Steve Livneh11
Steven Maclaren11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.